as legal lead for digital, data and privacy agreements, along with Business Associate Agreements as required under HIPAA.... Legal Research: Stay updated on legal and regulatory developments in the medical device industry and provide recommendations...
Associate Director of Regulatory Affairs-Chemistry, Manufacturing, and Controls (RA-CMC) in Japan will be responsible... for leading and providing Japan CMC regulatory support for the clinical and commercial product portfolio, which means managing...
Job Summary : The Japan Clinical Monitoring team is growing, and we are seeking a full-time an Associate Director... : Medpace is a full-service clinical contract research organization (CRO). We provide Phase I-IV clinical development services...
Job Summary The Japan Clinical Monitoring team is growing, and we are seeking a full-time an Associate Director... Medpace is a full-service clinical contract research organization (CRO). We provide Phase I-IV clinical development services...
【募集Summary】 Sr Records Management(RM) Associateは、IQVIAにおけるTMF Managementにおいて、TMF におけるDocument Processing(Imaging QC...を産前産後休暇とする ■育児休業:子供が1歳2ヵ月に達するまでを限度とし、本人の申し出た期間休業可能(やむを得ない場合は3歳まで可) ■介護休業 ■女性特別休暇 IQVIA is a leading global provider of clinical...
part. Responsible for developing staff(Senior ClinicalResearchAssociate and ClinicalResearchAssociate) capabilities... with clinicalresearch 【能力 / Skill-set】 <必須 / Mandatory> Effective in leading, motivating and empowering others in order...
and in discovery pharmacology, forensics, advanced material sciences and agroscience contract research services. It... material sciences and in the support of clinical studies, as well as having an emerging global presence in Contract Development...
about our company and new grads’ career opportunities at Medpace Japan. ClinicalResearchAssociate (CRA) and other professional roles... will be provided should you be selected to attend. Responsibilities ClinicalResearchAssociate (CRA) - join our growing team...
Power stocks to buy: Nomura has initiated coverage on Tata Power and JSW Energy, assigning them 'buy' ratings with target prices of ₹560 and ₹885. The firm anticipates robust growth in India's power sector, driven by renewable energy and increasing demand. Continue Reading »
Multibagger stock: Blue Cloud Softech has transformed from a penny stock to a multibagger, boasting a 1,321% rise over four years. Despite recent fluctuations, it remains a strong performer with significant growth potential, underscoring both the opportunities and risks of penny stock investments. Continue Reading »
While domestic challenges persist for Godrej Consumer Products, strategic shifts and steady international performance support a gradually improving outlook Continue Reading »
SME IPO: Shiv Texchem IPO was subscribed 7.67 times by Day 2. The ₹101.35 crore issue is priced at ₹158- ₹166 per share, with allotment set for October 11 and listing scheduled for October 15. Continue Reading »
The frontline benchmark Shanghai Composite index fell over seven per cent while the blue-chip CSI300 index also dropped 6.9 per cent. Continue Reading »
Top Gainers and Losers Today : The Sensex lost 167.71 points, or -0.21, to settle at 81634.81, while the Nifty lost 31.2 points, or -0.12, to close at 25013.15. Continue Reading »
Easy Trip Planners' shares rose over 4% on October 9 after announcing a board meeting on October 14 to discuss issuing bonus shares. The stock reached the day's high of ₹34.57 but remains 36% below its record high. Continue Reading »